Summary: Elevated concentrations of atrial natriuretic peptide reportedly mitigate acute renal failure in vivo and in the isolated perfused kidney (M. Nakamoto, J. L Shapiro, P. F. Shanley, L. Chan & R. W. Shrier (1987) J. Clin. Invest. 50, 698-705; S. G. Shaw, J. Weidmann, J. Hodler, A. Zimmermann & A. Paternostro (1987) J. Clin. Invest. 50, 1232 -1237). Since atrial natriuretic peptide has been shown to be a potent vasodilator, this beneficial effect may be due entirely to improved haemodynamics. To determine whether atrial natriuretic peptide also has a protective effect at the cellular level, rat hepatocyte cell cultures were treated with atrial natriuretic peptide prior to or after induction of cell damage by hypoxia (0.5% O 2 for 4 h) or reactive oxygen (hypochlorous acid). Bleb formation, degradation of radiolabeled trichloroacetic acid-precipitable peptides, release of lactate dehydrogenase and trypan blue exclusion were used äs indicators of cell damage. Atrial natriuretic peptide treatment distinctly protected the cell cultures against damage in both cases. This beneficial effect of atrial natriuretic peptide was partly mimicked by sodium nitroprusside, which, like atrial natriuretic peptide, largely increased the cellular cGMP content. 6-Anilino-5,8-quinolinedione (Ly 83583), an inhibitor of particulate guanylate cyclase, blocked the protective effect of atrial natriuretic peptide. Therefore a cGMPmediated mechanism seems to be involved in the cytoprotective action of atrial natriuretic peptide. Fluorometric measurements using the Ca 2+ -sensitive dye Quin-2 showed that the elevation of intracellular Ca 2 " 1 " after cellular insult by hypochlorous acid is prevented by atrial natriuretic peptide. These results suggest that atrial natriuretic peptide may attenuate hypoxic and toxic cell damage by increasing cGMP and reducing intracellular Ca 2+ .
Introduction
More recent reports have shown that elevated conAtrial nätriüfetic peptide, a hormone secreted from centrations of atrial natriuretic peptide can mitigate specific granules of the mammalian atria (l, 2), ex-post-ischaemic renal failure in vivo and in the isolated hibits several biological effects including vasorelaxa-perfused kidney (9, 10) . It is possible that this effect tion (3), natriuresis (2, 4) , and Inhibition of aldoster* is mediated entirely by increased vasodilatation and one-secretion (5) . Atrial natriuretic peptide opposes improved haemodynamics. The following study exthe vascular snaooth muscle contraction induced by amined whether atrial natriuretic peptide can also e. g. angiotensin II, norepinephrine, histamine and protect cells or cell cultures after exposure to hypoxia serotonin (6, 7) . Also, it has been shown that atrial and reactive oxygen (via hypochlorous acid), procenatriuretic peptide binds to specific receptors in the düres well known to induce cell damage similar to vascular tissue (8) . Therefore atrial natriuretic peptide post-ischaemic injury in vivo. Rat hepatocy tes were may play an important physiologieal role in circula-used, and these showed a considerable increase in tory homeostasis and haemodynamics. cGMP content after atrial natriuretic pepüde stimu-lation, suggesting the presence of atrial natriuretic peptide receptors. Cell damage in hepatocytes was assessed by the increased Formation of membrane extrusions (blebs), the increased degradation of radiolabeled polypeptides, the release of lactate dehydrogenase and the uptake of trypan blue, äs described previously (11 -13) . Changes in intracellular free Ca 2+ , which may play a central role in toxic and ischaemic cell injury (14) , were monitored using the Ca 2+ -sensitive fluorescent dye, Quin-2. Our study demonstrates that the beneficial effect of atrial natriuretic peptide observed after ischaemia and hypoxia in the kidney may also be due to protective effects of atrial natriuretic peptide at the cellular level.
Materials and Methods

Materials
Atrial natriuretic peptide, hypochlorous acid, sodium nitroprusside and Quin-2 (2-{[2-bis-(carboxymethyl)-amino-5-methylphenoxy]-methyl}-6-methoxy-8-bis-(carboxymethyl)-aminoquinoline) tetraacetoxymethyl ester were from Sigma Chemicals, Munich. Harris F-12 medium, Hanks" balanced salt solution, Dulbecco's modifled Eagle's medium and collagenase type II were from Seromed, Munich. All other solvents and chemicals were from Merck, Dannstadt. 6-Anilino-5,8-quinolinedione (Ly 83583) was a generous gift from Lilly Research Laboratories, Indianapolis, Ind.
Cell cultures
Hepatocytes were isolated from fed male Sprague-Dawley rats, weighing 150-200 g, by in situ perfusion of collagenase essentially äs described previously (12) . Yields of 0.2-0.4 · l O 9 cells per liver with 85-95% viability äs determined by trypan blue exclusion, were routinely obtained. The hepatocytes were plated at a density of 50 000/cm 2 in collagen-coated petri^penn dishes (Heraeus, DüsseldorO, containing Harris F-12 medium with foetal calf serum (volume fraction 0.10) at 37 °C in a humified atmosphere of 0.95 air and 0.05 CO 2 for 6 h. After incubation of cells for 6 h, the cells were washed with phosphate-buffered saline to remove the unattached dead cells. Harris F-12 medium supplemented with foetal calf serum (volume fraction 0.05) was replaced and the cells were incubated for further 20 h.
Hypoxia experiments
Experiments were initiated after the 20 h-old plated cells had been washed with phosphate-buffered saline and incubated in Harris F-12 medium supplemented with foetal calf serum (volume fraction 0.05) for 2h. The hepatocyte monolayers were divided into a 20%-O 2 and a 0.5%-O 2 (hypoxic) group. The 20%-O 2 group was placed in a Standard incubator with 0.05 CO 2 :0.95 air at 37 °C. The hypoxic group was incubated at 37 °C in 0.005 O 2 :0.05 CO 2 :0.945 N 2 . An oxygen electrode (Yellow Springs Instruments) was immersed in the medium of a culture dish to monitor O 2 concentration. Usually 80-90 min were required for equilibration of the O 2 concentration in the medium with the desired gas phase concentration. During hypoxia, atrial natriuretic peptide and other drugs (in salinestock Solutions equilibrated with the hypoxic gas) were added via an airlock. Viability of the eultured cells was assayed by trypan blue exclusion and release of lactate dehydrogenase, essentially äs described by Rubin & Farber (13) . The amount of enzyme in the supernatant was defined äs the percentage of total enzyme released after exposure of the cells to digitonin (2 g/l) for 30 min.
Treatment of hepatocytes with HC1O
In experiments with HC1O the 20 h-old plated cells were washed with a modified Krebs-Henseleit buffer containing dialysed bovine serum albumin (20 g/l), glucose (15 mmol/1), Hepes (20 mmol/l), pH 7.4 and incubated in the same buffer at 37 °C under an atmosphere of 0.95 O 2 , 0.05 CO 2 for 2 h without further additions. The plated hepatocytes were then checked by microscopy and trypan blue exclusion to ensure viability. HC1O (0.1 mmol/1) was added to intact cultures äs indicated without further changes of the medium. Readjustment of the pH after addition of HC1O was not necessary. Controls contained the appropriate solvents without HC1O. All assays were done in triplicate.
cGMP/cAMP determinations Isolated hepatocytes (l 10 9 /1) were washed twice with Dul· beccö's modified Eagles medium and then preincubated in culture dishes for 15 min in Dulbecco*s modified Eagle's medium containing 10 mmol/l Hepes (pH 7.3) and 0.5 mmol/1 isobutylmethylxanthine at 37 °C (0.05 CQ 2 , 0.95 air). Atrial natriuretic peptide and/or other drugs were added to the cells for various times äs indicated. After rapid centrifugation, the medium was aspirated, and 0.75-1 ml of ice^cold trichloroacetic acid (60 g/l) was added to the cells. The intracellular cGMP and cAMP content was then measured by commercially available radioimmunoassay kits (New England Nuclear, Dreieich) äs described (15) .
Bleb formation, proteolysis of cellular polypeptides
In some experiments cell damage was also assessed by determining the percentage increase of membrane blebs äs described previously (11) . The rate of intracellular proteolysis was measured by the method of Seglen et al. (16) äs modified by von Ruecker et al. (12) .
Measurement of cytosolic free Ca 2+ concentration
Isolated hepatocytes were incubated with Quhv2 tetraacetoxymethyl ester (Quin-2/AM) essentially äs described by Nicchitta et al. (17) . Briefly, cells were incubated at a concentration of 3 10 9 /l in modified Hank 9 s medium supplemented with 20 g/l dialysed bovine serum albumin, and Quin-2/AM was added to a final concentration of 50 umol/1. After loading of hepatoey tes for 15 min, the cells were washed twice in modified Hank's buffer, containing l mmol/1 CaCl 2 and l mmol/1 MgCl 2 . The cells were then resuspended in the same buffer at a cell concentration of l 10 9 /1, and the fluorescence was recorded before and after HClO-treatment in a Perkin Eimer LS-5 spectroftuorometer. The excitation wavelength was 339 nm and the eniission was recorded at 500 nm using a cutoff filter. The cuvette chämber was kept at 37 °C arid the cells were continuously stirred under an atmosphere of 0.95 O 2 , 0.05 CO 2 . Values for intracellular free Ca 2+ were estimated by the method of Tsien et al. (18) .
Results and Discussion
Effect of atrial natriuretic peptide and different drugs on cGMP/cAMP accumulation in hepatocytes
The increase in cellular cGMP content at different atrial natriuretic peptide concentrations in hepatocytes is shown in figure l. At optimal concentrations (^0.1 μιηοΐ/ΐ), atrial natriuretic peptide caused a 12-15-fold increase in cellular cGMP. Table l shows that atrial natriuretic peptide did not alter the cellular cAMP content of hepatocytes, in contrast to the effect observed by others in cardiocytes (19) . Sodium nitro- Hepatocytes were prepared and incubated at 37 °C for 10 min in the absence and presence of atrial natriuretic peptide s described in Methods. The cGMP levels in the cells were measured by radioimmunoassay (15 Protective effect of atrial natriuretic peptide on hepatocyte monolayers exposed to hypoxia and reoxygenation
Hepatocyte monolayers were exposed to 0.5% oxygen for 4 h; this low oxygen concentration has been shown to cause hypoxic injury in hepatocytes after reoxygenation (22) . Figure 2 shows that with no reoxygenation period after hypoxia, the cells remained viable s judged by trypan blue exclusion. Also, the release of lactate dehydrogenase from the hypoxic cells into the supernatant was not notably increased compared with controls ( fig. 2b) . Atrial natriuretic peptide (l μτηοΐ/ΐ), given at the indicated intervals during hypoxia, and the inhibitpr von 6-anilino-5,8-quinolinedione (Ly 83583) (10 μιηοΐ/ΐ) did not change the outcome of the 0 h-reoxygenation experiment. On the other hand, if the cells were exposed to prolonged Isolated hepatocytes were incubated at 37 °C for 10 min in the presence of either atrial natriuretic peptide, sodium nitroprusside or the combination of both agents, s described in Methods. 6-Anilino-5,8-quinolinedione (Ly 83583) was added 5 min prior to addition of atrial natriuretic peptide. The intracellular cGMP and cAMP levels were measured by radioimmunoassay s described (15) . Each value represents the mean ± S.E. from 7 different experiments performed in triplicate. 20 h reoxygenation, the survival rate was low (trypan blue exclusion was observed in less than 15% of the cells) and most cells were lysed s judged by the release of lactate dehydrogenase ( fig. 2a and 2b) . Atrial natriuretic peptide treatment, given before, during or after hypoxia, distinctly increased the survival rate and lessened cell lysis; atrial natriuretic peptide was most effective when added before hypoxia, and the beneficial effect was notably less when atrial natriuretic peptide was given after a 2 or 4h hypoxia period. 6-Anilino-5,8-quinolinedione (Ly 83583), which suppressed the atrial natriuretic peptide-mediated formation of cGMP (tab. 1), greatly diminished the cytoprotective effect of atrial natriuretic peptide ( fig. 2) . Therefore, a cGMP-dependent mechanism seems to be involved in atrial natriuretic peptideinduced cytoprotection.
In these experiments detectable d mage to the cells occurred after the physiological oxygen concentration had been restored, rather than during the hypoxic period itself. This so-called 'reoxygenation effect' after hypoxia has been observed by several authors in various tissues (for review see L c. (23)), and it has been attributed to increased lipid peroxidation, by the reactive oxygen that is formed after reoxygenation. Similar reoxygenation effects in hepatocytes exposed to hypoxia have been observed by Costa et al. (22) . Nevertheless, since atrial natriuretic peptide was more beneficial when it was added earlier during hypoxia ( fig. 2) , some irreversible detrimental events, even though not detectable by the methods employed, seem to occur during hypoxia.
Protective effect of atrial natriuretic peptide after treatment of hepatocyte monolayers with bypochlorous acid Hypochlorous acid fonris reactiVe oxygen when exposed to diffuse daylight (HC1O -> O + HC1). In order to study the effects of reactive oxygen, whieh is kn wn to dversely influence tissues during reoxygenation (23), we decided to apply HC1O to hepato- cyte monolayers. Again atrial natriuretic peptide was used in HClO-treated monolayers to determine its Potential s a cytoprotective agent. Nitroprusside, which like atrial natriuretic peptide, increased the cellular cGMP content of hepatocytes (but via soluble guanylate cyclase) (tab. 1), was also tested . Fig re 3 shows that all indicators of the onset of cell damage (i.e. bleb formation, trypan blue uptake, release of lactate dehydrogenase, increase in proteolysis) were distinctly increased if the cells were treated with HCIO (0.1 mmol/1) for 30 min at 37 °C. Pretreatment of cells with atrial natriuretic peptide (l μπιοΐ/ΐ) or nitroprusside (10 μηιοΐ/ΐ) nearly abolished the cell-d maging effects of HC1Q (0.1 mrn l/1). 6-Anilino-5,8-quinolinedione (Ly 83583) (10 μιροΐ/ΐ), which blocks atrial natriuretic peptide-dnduced activation of the particulate guanylate cyclase, largely inhibited the protective action of atrial natriuretic peptide ( fig. 3) . Controls done in the presence of these drugs but without HCIO did not differ from normal controls (data not shown). These observations suggest that, s in the case of hypoxic cell injury ( fig. 2) , atrial natriuretic peptide also induces cytoprotective action after cellular insult by HCIO (or reactive oxygen). A cGMP-dependent mechanism seems to be involved. Ca 2+ in hepatocytes by atrial natriuretic peptide. Isolated hepatocytes were loaded with Quin-2 and incubated at 37 °C in an spectrofluorometer s described in Methods. Fluorescence was measured once or twice per min. After stabilization of the Quin-2 signal (approx. 2 min), a solvent with or without atrial natriuretic peptide (l μιηοΐ/ΐ) was added l min prior to the addition of HC1O (0.1 mmol/1). Cytosolic Ca 2+ levels were determined s described by Tsien et al. (18) 
Increase of intracellular Ca
Concluding Remarks
Our results show that atrial natrijufetic peptide can protect hepatocytes after hypoxic and toxic (HC1O) insult. The beneficial effects of elevated atrial natriuretic peptide concentrations observed in acute ischaemic renal failure (9) and in the isolated perfused kidney (10) may therefore not only be due to atrial natriuretic peptide-induced vasodilatation and improved haemodynamics, but also to atrial natriuretic peptide-induced protection at the cellular level. The cytoprotective actipns of atrial natriuretic peptide were mimicked in our experiments by nitroprusside, which, like atrial natriuretic peptide, increases the cGMP content in the cell. 6-Anilino-5,8-quinolined ione (Ly 83583), which inhibits activation of the particulate guanylate cyclase by atrial natriuretic peptide, largely blocked the protective effect f atrial natriuretic peptide. Therefore the Formation of cGMP and cGMP-dependent mechanisms seem important for cytoprotectioii by atrial natriuretic peptide. Since HClO-induced cell injury and the accompanying increase in intracellular Ca 2+ were simultaneously prevented by atrial natriuretic peptide, it is reasonable to assume that the cytoprotective effects of atrial natriuretic peptide are mediated by Systems involved in the maintenance of cellular Ca 2+ balance. Via cGMP-dependent mechanisms, atrial natriuretic peptide may be involved in the modulation of the gating of voltager-dependent Ca 2+ channels (26) , or in the modulation of the Ca 2 +-pumping ATPase and the Na^/Ca 2 ·*· exchange System present in the cell membrane (27, 28) . The exact mechanism of atrial natriuretic peptide remains to be elucidated.
